Stay updated on Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial

Sign up to get notified when there's something new on the Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed from the page.
    Difference
    0.0%
    Check dated 2026-01-14T02:14:28.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Minor site update: added Revision: v3.3.3; removed HHS Vulnerability Disclosure and Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T17:21:36.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and v3.2.0 was removed from the page, indicating a minor version update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T21:29:15.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The government funding status banner was removed from the page; it previously warned about potential delays in updates.
    Difference
    0.3%
    Check dated 2025-11-17T19:13:09.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    The DENIVOS study page shows only minor administrative edits, including formatting tweaks and an updated timestamp. There are no changes to core trial details, eligibility criteria, or the list of participating sites. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T13:16:31.000Z thumbnail image
  8. Check
    104 days ago
    Change Detected
    Summary
    - Added a government funding notice and open status details (affects trust and usage guidance). - Updated version from v3.1.0 to v3.2.0 and removed the old version reference.
    Difference
    3%
    Check dated 2025-10-06T04:14:34.000Z thumbnail image

Stay in the know with updates to Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial page.